Claims
- 1. A method for treating psoriasis in mammals which comprises administering an antipsoriatic-effective amount of 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline, 2,4-diamino-5-chloro-6-[(3,4-dichloroanilino)methyl]quinazoline or a pharmaceutically acceptable salt thereof, to a mammal in need of said treatment.
- 2. The method of claim 1 wherein 0.07 mg to 7.1 mg/kg of weight per day of said compound is administered.
- 3. The method of claim 1 wherein said compound is 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline monoacetate.
- 4. The method of claim 1 wherein said compound is 2,4-diamino-5-chloro-6-[(3,4-dichloroanilino)methyl]quinazoline monoacetate.
- 5. The method defined in claim 1 wherein said mammal is a human.
Parent Case Info
This is a continuation of application Ser. No. 84,944 filed Oct. 15, 1979, now abandoned.
Foreign Referenced Citations (1)
| Number |
Date |
Country |
| 1345502 |
Jan 1974 |
GBX |
Continuations (1)
|
Number |
Date |
Country |
| Parent |
84944 |
Oct 1979 |
|
Patent Grant
4391809
